Plant Summary


  Plant Information

TCMBank_ID:

TCMBANKHE006306
TCMBANKHE005241
TCMBANKHE003733
TCMBANKHE007704

YEM_ID:

YEM-396

ID:

TCMBANKHE006306/YEM-396
TCMBANKHE005241/YEM-396
TCMBANKHE003733/YEM-396
TCMBANKHE007704/YEM-396

植物拉丁名:

Melia azedarach var. japonica|Melia azedarach
显示图片
Melia azedarach
显示图片

功能与主治:

To clear heat and dry damp, kill worms and relieve itch, move qi and relieve pain./Eczema titillation, sore lichen and scab lai, snake or insect bites, trichomonal vaginitis, mounting qi (hernia), painful swelling from knocks and falls.
To clear heat and dispel damp, kill worms and relieve itch./Prickly heat.
To move qi and relieve pain, kill worms./Pain in stomach duct and rib-side, mounting pain, abdominal pain due to worm accumulation, tinea capitis, frostbite (kibe).

药用植物名:

日本苦楝|棟
苦楝叶|棟
莲花|棟
苦楝实|棟

药名:

苦棟皮

来源:

云南民族药物志:第二卷

药用部位:

leaf
flower
fruit

使用民族:

阿昌族/布依族/傣族/德昂族/景颇族/傈僳族/苗族/普米族/佤族/瑶族/彝族/壮族

TCM_ID_id:

1584
6063
5138
3464


   植物对应的化合物
化合物ID 化合物名 别名 分子式 分子质量 Smiles
TCMBANKIN016304 10-deactyltyunnanaxane C16H10O8
TCMBANKIN025619 (+)-Catechin-5-O-glucoside (2S,3R,4S,5S,6R)-2-[[(2R,3S)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-5-chromanyl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; (2S,3R,4S,5S,6R)-2-[(2R,3S)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-chroman-5-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol; (2S,3R,4S,5S,6R)-2-[(2R,3S)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxychroman-5-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol; (+)-catechin-5-o-glucoside; (2S,3R,4S,5S,6R)-2-[(2R,3R)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-chroman-5-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; (2S,3R,4S,5S,6R)-2-[(2R,3S)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-chroman-5-yl]oxy-6-methylol-tetrahydropyran-3,4,5-triol; (2S,3R,4S,5S,6R)-2-[(2R,3S)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-chroman-5-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; (?)-Epicatechin-5-O-beta-D-glucopyranoside C21H24O11 452.4 g/mol C1C(C(OC2=C1C(=CC(=C2)O)OC3C(C(C(C(O3)CO)O)O)O)C4=CC(=C(C=C4)O)O)O
TCMBANKIN033226 senecionine C18H25NO5 335.4 g/mol CC=C1CC(C(C(=O)OCC2=CCN3C2C(CC3)OC1=O)(C)O)C
TCMBANKIN034482 sendanone acetate [5-(3,3-dimethyloxiran-2-yl)-3-[(10R)-4,4,10,13,14-pentamethyl-3-oxo-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]oxolan-2-yl] acetate; AC1NT0C1 CC(=O)OC1C(CC(O1)C2C(O2)(C)C)C3CCC4(C3(CCC5C4=CCC6C5(CCC(=O)C6(C)C)C)C)C
TCMBANKIN038727 melianone C30H46O4 471 C([H])([H])([H])C1(C([H])([H])[H])C(=O)C([H])([H])C([H])([H])[C@@](C([H])([H])[H])([C@]([H])(C([H])([H])C([H])([H])[C@]2(C([H])([H])[H])[C@@]3(C([H])([H])[H])C([H])([H])C([H])([H])[C@]2([H])[C@@]4([H] )[C@]([H])(O[H])O[C@@]([H])([C@@]5([H])OC5(C([H])([H])[H])C([H])([H])[H])C4([H])[H])C3=C([H])C6([H])[H])[C@]16[H]
TCMBANKIN050435 melianoninol C20H20O6 356.37 COC1=CC2=C(C=C1)OC(C2CO)C3=C(C=C(C(=C3)O)C=CC=O)OC
TCMBANKIN059292 toosendansterol b toosendansterol a C21H34O3 334.49 CC(C1C(=O)CC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C)O
TCMBANKIN026938 melicitrin C20H18O12 C1C(C(C(C(O1)OC2=CC(=CC(=C2O)O)C3=C(C(=O)C4=C(C=C(C=C4O3)O)O)O)O)O)O
TCMBANKIN036849 Toosendanin toosendanin C30H38O11 574.62 CC(=O)OC1CC(C23COC(C1(C2CC(C4(C3C(=O)C(C5(C46C(O6)CC5C7=COC=C7)C)OC(=O)C)C)O)C)O)O
TCMBANKIN047181 Isoliensinine 7-Isoquinolinol, 1,2,3,4-tetrahydro-1-((4-hydroxy-3-((1,2,3,4-tetrahydro-6-methoxy-1-((4-methoxyphenyl)methyl)-2-methyl-7-isoquinolinyl)oxy)phenyl)methyl)-6-methoxy-2-methyl-, (R-(R*,R*))-; 1-{[4-hydroxy-3-({6-methoxy-1-[(4-methoxyphenyl)methyl]-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-yl}oxy)phenyl]methyl}-6-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-7-ol; (1R)-1-[4-hydroxy-3-[[(1R)-6-methoxy-1-(4-methoxybenzyl)-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]oxy]benzyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol; Isoliensinine; Isoliensinin; 6817-41-0; (1R)-1-[[4-hydroxy-3-[[(1R)-6-methoxy-1-[(4-methoxyphenyl)methyl]-2-methyl-3,4-dihydro-1H-isoquinolin-7-yl]oxy]phenyl]methyl]-6-methoxy-2-methyl-3,4-dihydro-1H-isoquinolin-7-ol; 7-Isoquinolinol, 1,2,3,4-tetrahydro-1-[[4-hydroxy-3-[[(1R)-1,2,3,4-tetrahydro-6-methoxy-1-[(4-methoxyphenyl)methyl]-2-methyl-7-isoquinolinyl]oxy]phenyl]methyl]-6-methoxy-2-methyl-, (1R)-; AIDS-226951; AIDS226951 C39H45NO6 624 c1(OC([H])([H])[H])c([H])c(C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])[H])[C@]2(C([H])([H])[H])C([H])([H])c3c([H])c([H])c(OC([H])([H])[H])c([H])c3[H])c2c([H])c1Oc4c(O[H])c([H])c([H])c(C([H])([H])[C@] 5([H])c(c([H])c(O[H])c(OC([H])([H])[H])c6[H])c6C([H])([H])C([H])([H])N5C([H])([H])[H])c4[H]
TCMBANKIN058283 MELILOTATE C01198; 3-(2-hydroxyphenyl)propanoic acid; 3-(2-Hydroxyphenyl) propanoic acid; Melilotic acid; Oprea1_380863; 495-78-3; 3-(o-Hydroxyphenyl) propionic acid; 3-(2-Hydroxyphenyl) propionate; 2-hydroxybenzenepropanoic acid; 393533_ALDRICH; Benzenepropanoic acid, 2-hydroxy-; 3-(2-hydroxyphenyl)propanoate; InChI=1/C9H10O3/c10-8-4-2-1-3-7(8)5-6-9(11)12/h1-4,10H,5-6H2,(H,11,12; AIDS017764; AIDS-017764; ST5406932; 3-(2-Hydroxyphenyl)propionic acid; o-Hydroxyphenylpropionic acid; .beta.-(O-Hydroxyphenyl)propionic acid; CHEBI:16104; C9H10O3 166.17 g/mol C1=CC=C(C(=C1)CCC(=O)O)O
TCMBANKIN058638 higenamine UNII-6016M93W29; CHEBI:27751; (R)-Norcoclaurine; 6,7-Dihydroxy-(1R)-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline; 6,7-Isoquinolinediol, 1,2,3,4-tetrahydro-1-((4-hydroxyphenyl)methyl)-, (1R)-; (1R)-1-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol; 6016M93W29; SCHEMBL5898913; AX8328517; DTXSID90331552; (+)-HIGENAMINE; UNII-TBV5O16GAP component WZRCQWQRFZITDX-CQSZACIVSA-N; CHEMBL501778; 6,7-Isoquinolinediol, 1,2,3,4-tetrahydro-1-((4-hydroxyphenyl)methyl)-, (R)-; C06347; (R)-(+)-Higenamine; (+)-Demethylcoclaurine; 106032-53-5; BDBM50242856; AC1L9ACA; (1R)-1-(4-hydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol; AK00743742; (R)-1-(4-Hydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol; Higenamine, (+)-; ZINC896041; demethylcoclaurine; demetahyl coclaurine C16H17NO3 271.31 g/mol C1CNC(C2=CC(=C(C=C21)O)O)CC3=CC=C(C=C3)O
TCMBANKIN058641 (-)-anonaine C09339; 3,5-DIOXA-11-AZAPENTACYCLO[10.7.1.0(2),?.0?,(2)?.0(1)?,(1)?]ICOSA-1(20),2(6),7,14,16,18-HEXAENE; 1862-41-5; SCHEMBL15800852; 3,5-dioxa-11-azapentacyclo[10.7.1.0;{2,6}.0;{8,20}.0;{14,19}]icosa-1(20),2(6),7,14(19),15,17-hexaene; 1,2-Methylenedioxynoraporphine; Anonaine; J3.604.525F; Anonain; ACon1_001472; NCGC00180471-01; AC1MR46Q; (-)-Annonaine; 5H-Benzo(g)-1,3-benzodioxolo(6,5,4-de)quinoline, 6,7,7a,7-tetrahydro-, (R)-; (+)-Anonaine;anonaine C17H15NO2 265.31 g/mol C1CNC2CC3=CC=CC=C3C4=C2C1=CC5=C4OCO5
TCMBANKIN037417 nimbolidin a C40H48O12 720.8 CC1=C(C(CC1C2=COC=C2)OC(=O)C)C3(C(C4(C(CC(C5(C4C(C3OC(=O)C6=CC=CC=C6)OC5)C)OC(=O)C)OC(=O)C)C)CC(=O)OC)C
TCMBANKIN038877 15-O-Deacetyl-15-O-methylnimbolidin B
TCMBANKIN039134 Trichilin H 702.74
TCMBANKIN041093 15-o-deacetyl-15-o-methylnimbolidin a C39H48O11 CC1=C(C(CC1C2=COC=C2)OC)C3(C(C4(C(CC(C5(C4C(C3OC(=O)C6=CC=CC=C6)OC5)C)OC(=O)C)OC(=O)C)C)CC(=O)OC)C
TCMBANKIN047316 12-O-Deacetyltrichilin H 660.7 g/mol
TCMBANKIN047676 15-o-deacetylnimbolidin b C36H48O11 656.8 g/mol CC=C(C)C(=O)OC1C2C3C(CO2)(C(CC(C3(C(C1(C)C4=C(C(CC4O)C5=COC=C5)C)CC(=O)OC)C)OC(=O)C)OC(=O)C)C

   植物对应的疾病
疾病ID 病名 疾病类型 MeSH 参考文献
TCMBANKDI000052 Osteoporosis disease Nutritional and Metabolic Diseases; Musculoskeletal Diseases 31196982

   植物对应的靶点
靶点ID 基因名 基因别名 描述 染色体位置 Map_Location 基因类型
TCMBANKGE000974 SMAD5 DWFC; JV5-1; MADH5 SMAD family member 5 5 5q31.1 protein-coding
TCMBANKGE000977 SMAD1 BSP-1; BSP1; JV4-1; JV41; MADH1; MADR1 SMAD family member 1 4 4q31.21 protein-coding
TCMBANKGE001088 SMAD4 DPC4; JIP; MADH4; MYHRS SMAD family member 4 18 18q21.2 protein-coding
TCMBANKGE001108 BMP2 BDA2; BMP2A; SSFSC bone morphogenetic protein 2 20 20p12.3 protein-coding
TCMBANKGE003590 SMAD9 MADH6; MADH9; PPH2; SMAD8; SMAD8/9; SMAD8A; SMAD8B SMAD family member 9 13 13q13.3 protein-coding